Biotech & Bioprocessing

Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge
Biotech & Bioprocessing Thermo Fisher CEO Predicts Expansion and Growth Amid GLP-1 Demand Surge

In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive investment in its

Makerere University Launches Cybersecurity Initiative for Bio Labs
Biotech & Bioprocessing Makerere University Launches Cybersecurity Initiative for Bio Labs

Makerere University in Kampala, Uganda recently unveiled a groundbreaking initiative during its 75th graduation ceremony, targeting enhanced security measures for laboratory safety and administrative protocols. In collaboration with the Uganda Virus Research Institute (UVRI) and backed by the

How Can CRISPR and Biomaterials Improve Gene Therapy Safety?
Biotech & Bioprocessing How Can CRISPR and Biomaterials Improve Gene Therapy Safety?

The integration of CRISPR technology with biomaterials engineering offers a promising avenue for safer and more effective gene therapies. Tomas Gonzalez-Fernandez, an assistant professor at Lehigh University, has received funding from the National Science Foundation’s Faculty Early Career

Contract Development and Manufacturing Innovations in 2025
Biotech & Bioprocessing Contract Development and Manufacturing Innovations in 2025

The contract development and manufacturing organization (CDMO) industry has seen significant advancements and partnerships as of January 2025. With a focus on large molecules and advanced therapies, this article delves into the latest developments, highlighting key trends, common themes, and

Can Bioprinted Tissues Revolutionize Treatments for Endocrine Diseases?
Biotech & Bioprocessing Can Bioprinted Tissues Revolutionize Treatments for Endocrine Diseases?

Aspect Biosystems, a pioneer in the field of bioprinted tissue therapeutics, recently closed a $115 million Series B financing round aimed at advancing its groundbreaking technology in regenerative medicine. This achievement, led by Dimension and supported by investors such as Novo Nordisk and

How Does BCAR Aim to Revolutionize CGT Manufacturing and Patient Access?
Biotech & Bioprocessing How Does BCAR Aim to Revolutionize CGT Manufacturing and Patient Access?

The Blood and Cell Advocacy Register (BCAR) is a newly launched consortium that aims to revolutionize the development and commercialization of advanced therapy medicinal products (ATMPs). Formed in December 2024, BCAR brings together experts and organizations from the blood and cell industries to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later